Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
President 61 01/06/2010
Chief Tech/Sci/R&D Officer 47 01/05/2015
Director TitleAgeSince
Director/Board Member 61 01/06/2007
Director/Board Member 69 -
Director/Board Member 47 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%+0.18% - - 4.68Cr
+0.34%+1.09%-10.67%-5.05% 4.32TCr
+1.73%+3.59%+318.08%+564.04% 3.53TCr
+0.61%+1.34%+10.00%+46.20% 3.02TCr
+0.02%-5.93%+8.45%-21.44% 2.8TCr
-1.06%-3.71%+9.08%+19.56% 2.41TCr
-1.23%+2.11% - - 1.42TCr
-0.99%-2.53%+47.29%+102.88% 1.3TCr
+1.54%+0.16%+6.69%+8.89% 1.27TCr
+2.39%+2.61%+102.86%+84.20% 1.25TCr
Average +0.35%-0.27%+61.47%+99.91% 2.37TCr
Weighted average by Cap. +0.41%-0.20%+67.82%+117.75%
Logo DNA CHIP RESEARCH
DNA Chip Research Inc. is primarily engaged in DNA chip-related analysis and next-generation sequence related technology research business, and diagnostic business which is engaged in the sales of medical-related equipment centered on EGFR-NGS Check. The Contract Research segment is engaged in the microarray, next-generation sequencing experiment analysis to universities and research institutes, pharmaceutical and food companies. The Diagnostic segemnt utilizes genetic analysis technology to disseminate tests corresponding to social needs on personalized medicine and undiseased society. The main menu of the diagnostic business is EGFR-NGS Check. The Research and Development segment includes research on cancer diagnosis technology using next generation sequencer, as well as the development of RNA check.
Employees
37
  1. Stock Market
  2. Stocks
  3. 2397 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!